Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 239-247

  Lentsch, Alex B ^a,b   Jordan, Jacqueline A ^b   Czermak, Boris J ^c   Diehl, Kathleen M ^b   Younkin, Ellen M ^b   Sarma, Vidya ^b   Ward, Peter A ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHEMOKINE; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; I KAPPA B; LEUKOCYTE ELASTASE INHIBITOR; PROTEIN; SLPI PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MALE; MOLECULAR INTERACTION; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ANTIGEN ANTIBODY COMPLEX; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LONG EVANS RAT; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; IMMUNOGLOBULIN G; LUNG; MALE; NF-KAPPA B; PNEUMONIA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RATS; RATS, LONG-EVANS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 0032590012     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65270-4     Document Type: Article

References (36)

1. Van Seuningen I, Audie JP, Gosselin B, Lafitte JJ, Davril M: Expression of human mucous proteinase inhibitor in respiratory tract: a study by in situ hybridization. J Histochem Cytochem 1995, 43:645-648
2. De Water R, Willems LN, Van Muijen GN, Franken C, Fransen JA, Dijkman JH, Kramps JA: Ultrastructural localization ol bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am Rev Respir Dis 1986, 133:882-890
3. Sallenave JM, Silva A, Marsden ME, Ryle AP: Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am J Respir Cell Mol Biol 1993, 8:126-133
4. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J: Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastasespecific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994, 11:733-741
5. Jin F, Nathan C, Radzioch D, Ding A: Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997, 88:417-426
6. Sallenave JM, Si-Tahar M, Cox G, Chignard M, Gauldie J: Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leuk Biol 1997, 61:695-702
7. Lucey EC, Stone PJ, Ciccolella DE, Breuer R, Christensen TG, Thompson RC, Snider GL: Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J Lab Clin Med 1990, 115:224-232
8. Rudolphus A, Kramps JA, Dijkman JH: Effect of human antileucoprotease on experimental emphysema. Eur Resp J 1991, 4:31-39
9. Gillissen A, Birrer P, McElvaney NG, Buhl R, Vogelmeier C, Hoyt RF Jr, Hubbard RC, Crystal RG: Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol 1993, 75:825-832
10. Linden M, Hakansson L, Ohlsson K, Sjodin K, Tegner H, Tunek A, Venge P: Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation 1989, 13:651-658
11. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995, 96:456-464
12. Johnson KJ, Ward PA: Acute immunologic pulmonary alveolitis. J Clin Invest 1974, 54:349-357
13. Welbourn CR, Young Y: Endotoxin, septic shock, and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 1992, 79:998-1003
14. Turnage RH, Guice KS, Oldham KT: Pulmonary microvascular injury following intestinal reperfusion. New Horiz 1994, 2:463-475
15. Ratliff NB, Wilson JW, Mikat E, Hackel DB, Graham TC: The lung in hemorrhageic shock: IV. The role of neutrophilic polymorphonuclear leukocytes. Am J Pathol 1971, 65:325-334
16. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA: Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993, 142:1739-1749
17. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward PA: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991, 88:1396-1406
18. Johnson KJ, Ward PA: Role of oxygen metabolites in immune complex injury of lung. J Immunol 1981, 126:2365-2369
19. Bless NM, Smith D, Charlton J, Czermak BJ, Schmal H, Friedl HP, Ward PA: Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol 1997, 7:877-880
20. Lentsch AB, Czermak BJ, Bless NM, Ward PA: NF-κB activation during IgG immune complex-induced lung injury: requirements for TNF-α and IL-1β but not complement. Am J Pathol 1998, 152:1327-1336
21. Mulligan MS, Desrochers PE, Chinnaiyan AM, Gibbs DF, Varani J, Johnson KJ, Weiss SJ: In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor, and tissue inhibitor of metalloproteinases 2. Proc Natl Acad Sci USA 1993, 90:11523-11527
22. Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM: Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997, 99:894-900
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
24. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: I kappa B-β regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995, 80:573-582
25. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986, 95:99-105
26. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol 1997, 158:3439-3448
27. Schmid E, Piccolo MT, Friedl HP, Warner RL, Mulligan MS, Hugli TE, Till GO, Ward PA: Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock 1997, 8:119-124
28. Suzuki K, Sasagawa OH, Sakatani S, Fujikura T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983, 132:345-352
29. Lentsch AB, Shanley TP, Sarma V, Ward PA: In vivo suppression of NF-kappa B, and preservation of I kappa B α by interleukin-10, and interleukin-13. J Clin Invest 1997, 100:2443-2448
30. Weil R, Laurent-Winter C, Israel A: Regulation of IκBβ degradation similarities to and differences from IκBα. J Biol Chem 1997, 272: 9942-9949
31. Baldwin AS: The NF-kappa B, and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683
32. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, Ward PA: Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989, 84:1873-1882
33. Warren JS: Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the rat. Biochem Biophys Res Commun 1991, 175: 604-610
34. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA: Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997, 159:3483-3489
35. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995, 9:899-909
36. McNeely TB, Shugars DC Rosendahl M, Tucker C, Eisenberg SP, Wahl SM: Inhibition of human immunodeficiency virus type I infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997, 90:1141-1149